Publications by authors named "Alessio Somaschini"

Claim this Profile
A
A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell Lines.
Fabio Gasparri, Ivan Fraietta, Laura Gianellini, Marisa Montemartini, Laura Raddrizzani, Alessio Somaschini

Methods Mol Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining potentially actionable kinase gene fusions in cancer cell lines with the KuNG FU database.
Alessio Somaschini, Sebastiano Di Bella, Carlo Cusi, Laura Raddrizzani, Antonella Leone

Sci Data· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive kinome NGS targeted expression profiling by KING-REX.
Giovanni Carapezza, Carlo Cusi, Ettore Rizzo, Laura Raddrizzani, Sebastiano Di Bella, Alessio Somaschini

BMC Genomics· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Paola Magnaghi, Barbara Salom, Liviana Cozzi, Nadia Amboldi, Dario Ballinari, Alessio Somaschini

Mol Cancer Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Roberta Bosotti, Paola Magnaghi, Sebastiano Di Bella, Liviana Cozzi, Carlo Cusi, Alessio Somaschini

Sci Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Andrea Sartore-Bianchi, Elena Ardini, Roberta Bosotti, Alessio Amatu, Emanuele Valtorta, Alessio Somaschini

J Natl Cancer Inst· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Alessio Amatu, Alessio Somaschini, Giulio Cerea, Roberta Bosotti, Emanuele Valtorta

Br J Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
Elena Ardini, Roberta Bosotti, Andrea Lombardi Borgia, Cristina De Ponti, Alessio Somaschini

Mol Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authentication.
Alessio Somaschini, Nadia Amboldi, Angelo Nuzzo, Emanuela Scacheri, Giorgio Ukmar

Genet Test Mol Biomarkers· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis